⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Clinilabs and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Clinilabs
↗New York City, USA
Clinilabs is a global, full-service contract research organization (CRO) that specializes exclusively in central nervous system (CNS) drug, device, and technology development. The company provides comprehensive clinical development services, including project management, biostatistics, data management, and regulatory support, to pharmaceutical, biotechnology, and medical device companies.
With over 25 years of experience, Clinilabs has completed more than 800 CNS-focused clinical trials and contributed to the approval of over 30 marketed products. The company is recognized for its deep indication-level expertise in psychiatry, neurology, substance use disorders, and rare CNS diseases, operating across North America and Europe with a focus on high-quality, data-driven clinical research.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Founded:2001
Ownership:private
Status:operating
FUNDING
Stage:Private Equity
Investors:InTandem Capital Partners
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Medical Devices, Digital Health
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Rutgers University (Clinical research training), Decentralized Trials & Research Alliance (DTRA)
COMPETITION
Position:Niche Player
Competitors:SSI Strategy, Fusion Antibodies, ProductLife Group
LEADERSHIP
Key Executives:
Gary Zammit - President and CEO
Jeanine M. Falinski - Chief Commercial Officer
Scientific Founders:Gary Zammit
LINKS
Website:clinilabs.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Clinilabs. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.